Induction of hepatitis B virus surface antigen-specific cytotoxic T lymphocytes can be up-regulated by the inhibition of indoleamine 2, 3-dioxygenase activity

Immunology

Volumn 142, Issue 4, 2014, Pages 614-623

  Ito, Hiroyasu ^a   Ando, Tatsuya ^a   Ando, Kazuki ^a   Ishikawa, Tetsuya ^b   Saito, Kuniaki ^c   Moriwaki, Hisataka ^a   Seishima, Mitsuru ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

3 dioxygenase; Cytotoxic T lymphocyte; Hepatitis B virus; Indoleamine 2; Vaccination

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD8 ANTIGEN; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY ASSAY; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNIZATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE; UPREGULATION;

3-DIOXYGENASE; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; INDOLEAMINE 2; VACCINATION;

ANIMALS; ANTIGENS, CD11B; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-12; INTERLEUKIN-2; MICE; MICE, KNOCKOUT; UP-REGULATION;

EID: 84904045518     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12274     Document Type: Article

References (35)

1. Guidotti LG. The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection. Vaccine 2002; 20(Suppl 4):A80-2.
2. Shan L, Deng K, Shroff NS et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 2012; 36:491-501.
3. Ito H, Seishima M. Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell. J Biomed Biotechnol 2010; 2010:641757.
4. Kim D, Hung CF, Wu TC, Park YM. DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells. Vaccine 2010; 28:7297-305.
5. + NKT cells promotes the breakage of CTL tolerance. Int Immunol 2008; 20:869-79.
6. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999; 189:1363-72.
7. Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999; 20:469-73.
8. Fujigaki S, Saito K, Sekikawa K et al. Lipopolysaccharide induction of indoleamine 2, 3-dioxygenase is mediated dominantly by an IFN-γ-independent mechanism. Eur J Immunol 2001; 31:2313-8.
9. Hoshi M, Saito K, Hara A et al. The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse. J Immunol 2010; 185:3305-12.
10. Hoshi M, Matsumoto K, Ito H et al. l-Tryptophan-kynurenine pathway metabolites regulate type I IFNs of acute viral myocarditis in mice. J Immunol 2012; 188:3980-7.
11. Fallarino F, Grohmann U, Hwang KW et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4:1206-12.
12. Grohmann U, Fallarino F, Bianchi R et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 2003; 198:153-60.
13. Ito H, Hoshi M, Ohtaki H et al. Ability of IDO to attenuate liver injury in α-galactosylceramide-induced hepatitis model. J Immunol 2010; 185:4554-60.
14. Ando K, Guidotti LG, Wirth S et al. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 1994; 152:3245-53.
15. Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV. CTL access to tissue antigen is restricted in vivo. J Immunol 1994; 153:482-8.
16. Kasahara S, Ando K, Saito K et al. Lack of tumor necrosis factor α induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J Virol 2003; 77:2469-76.
17. Nakagawa Y, Watari E, Shimizu M, Takahashi H. One-step simple assay to determine antigen-specific cytotoxic activities by single-color flow cytometry. Biomed Res 2011; 32:159-66.
18. Ito H, Ando K, Nakayama T et al. Role of Vα14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 2003; 38:1116-24.
19. Ito H, Ando K, Ishikawa T et al. Role of TNF-α produced by nonantigen-specific cells in a fulminant hepatitis mouse model. J Immunol 2009; 182:391-7.
20. Ohtaki H, Ito H, Hoshi M et al. High susceptibility to lipopolysaccharide-induced lethal shock in encephalomyocarditis virus-infected mice. Sci Rep 2012; 2:367.
21. Mandapathil M, Lang S, Gorelik E, Whiteside TL. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 2009; 346:55-63.
22. + dendritic cell subset in inducing type 1 immunity against infection. J Immunol 2010; 184:2095-106.
23. Yan Y, Zhang GX, Gran B et al. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 2010; 185:5953-61.
24. + dendritic cells express indoleamine 2, 3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010; 59:595-604.
25. Bachmann MF, Schorle H, Kuhn R et al. Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4. J Virol 1995; 69:4842-6.
26. Widmer MB, Grabstein KH. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 1987; 326:795-8.
27. Terness P, Bauer TM, Rose L et al. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002; 196:447-57.
28. Fallarino F, Grohmann U, Puccetti P. Indoleamine 2, 3-dioxygenase: from catalyst to signaling function. Eur J Immunol 2012; 42:1932-7.
29. Murakami Y, Hoshi M, Hara A et al. Inhibition of increased indoleamine 2, 3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection. Cytokine 2012; 59:245-51.
30. + cytotoxic T cell responses by inducing CD70 expression on dendritic cells. J Immunol 2008; 180:4615-20.
31. Yu J, Du W, Yan F et al. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J Immunol 2013; 190:3783-97.
32. Scott GN, DuHadaway J, Pigott E et al. The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity. J Immunol 2009; 182:7509-17.
33. Eleftheriadis T, Sparopoulou T, Antoniadi G, Liakopoulos V, Stefanidis I, Galaktidou G. Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration. Daru 2011; 19:236-9.
34. Pigott E, Mandik-Nayak L. Addition of an indoleamine 2, 3, -dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice. Arthritis Rheum 2012; 64:2169-78.
35. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25-36.